Table 3.

Adverse events in 43 treated patients

n (%)
Drug-related adverse events (≥10% of patients)
    Diarrhea9 (21)
    Nausea6 (14)
    Fatigue6 (14)
Drug-related grade 3/grade 4 adverse events, any incidence
    Any grade 3 or grade 4 adverse event4 (9)
    Lung infiltration1 (2)
    Hypersensitivity1 (2)
    Dyspnea and acute respiratory distress syndrome1 (2)
    Diarrhea1 (2)
    Cardiac toxicity or confirmed LVEF decrease ≥10% and post-baseline LVEF <50%0 (0)